Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) hit a new 52-week low on Thursday . The stock traded as low as $13.00 and last traded at $13.00, with a volume of 102 shares changing hands. The stock had previously closed at $15.77.
Analyst Ratings Changes
Several analysts have recently commented on TLX shares. UBS Group initiated coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They issued a “buy” rating and a $21.00 target price for the company. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research note on Tuesday, November 19th.
Get Our Latest Stock Report on Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited American Depositary Shares Price Performance
Telix Pharmaceuticals Limited American Depositary Shares Company Profile
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Featured Stories
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- The 3 Best Fintech Stocks to Buy Now
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- How to Use the MarketBeat Stock Screener
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- What is a Dividend King?
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
